The Effect of Soy Isoflavones on Non-alcoholic Fatty Liver Disease and the Level of FGF-21 and Fetuin A

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

September 6, 2022

Primary Completion Date

March 12, 2023

Study Completion Date

May 11, 2023

Conditions
NAFLD
Interventions
DIETARY_SUPPLEMENT

Soy isoflavone

the subjects in the soy isoflavone group were told to take 2 drugs per day, one in the morning after the breakfast and one at night after the dinner and continue this pattern for 12 weeks.

OTHER

Placebo

the subjects in the placebo group were told to take 2 placebo tablets per day, one in the morning after the breakfast and one at night after the dinner and continue this pattern for 12 weeks.

Trial Locations (1)

78531-67465

Asal Neshatbini Tehrani, Ahvāz

All Listed Sponsors
lead

Ahvaz Jundishapur University of Medical Sciences

OTHER